Saturday, October 31, 2026

EUR/JPY Is 5% Up In The Last 21 Sessions

EUR/JPY Is 5% Up In The Last 21 Sessions

(VIANEWS) - EUR/JPY (EURJPY) has been up by 5.1% for the last 21 sessions. At 05:08 EST on Monday, 3 July, EUR/JPY (EURJPY) is $157.60.

EUR/JPY's yearly highs and lows, it's 18.128% up from its 52-week low and 0.247% down from its 52-week high.

Volatility

EUR/JPY's last week, last month's, and last quarter's current intraday variation average was 0.07%, 0.24%, and 0.47%, respectively.

EUR/JPY's highest amplitude of average volatility was 0.22% (last week), 0.39% (last month), and 0.47% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/JPY's Forex is considered to be oversold (<=20).

News about

  • Eur/usd to be around the 1.15 level by the end of next year – bofa. According to FXStreet on Monday, 3 July, "Economists at the Bank of America expect the EUR/USD pair to hover around 1.15 by the end of 2024.", "Beyond that, we predict that EUR/USD will move towards its fair value in the 1.20s."
  • Eur/usd struggles for a firm intraday direction, consolidates in a range above 1.0900 mark. According to FXStreet on Monday, 3 July, "This remains supportive of elevated US Treasury bond yields, which lend support to the USD and cap the EUR/USD pair.", "That said, the emergence of some US Dollar (USD) buying, supported by the Federal Reserve's (Fed) hawkish stance, is holding back bulls from placing aggressive bets around the EUR/USD pair and acting as a headwind. "
  • Eur/usd price analysis: retreats from 1.0920 resistance confluence as eu/us pmis loom. According to FXStreet on Monday, 3 July, "Overall, the EUR/USD pair buyers are likely to keep the reins unless breaking the 1.0815 support levels even if the short-term downside is expected.", "That said, the bullish MACD signals and the steady RSI (14) line contrast with the EUR/USD pair's latest retreat to suggest the quote's intraday fall toward an ascending support line from May 31, close to 1.0860."
  • Eur/usd grinds higher past 1.0900 ahead of fed minutes, NFP. According to FXStreet on Sunday, 2 July, "Hence, EUR/USD traders may witness hardships in extending the latest recovery should this week's Federal Open Market Committee(FOMC)Monetary policy meeting Minutes and the US jobs report offer upbeat signals. ", "A daily closing beyond a downward-sloping resistance line from June 22, close to 1.0920 by the press time, becomes necessary for the EUR/USD bulls to retake control."

More news about EUR/JPY (EURJPY).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com